Medytox Inc., 10% Owner at Evolus, Inc. (EOLS), bought 284,000 shares at $11.03 ($3.2M) on 2021-08-23, disclosed to the SEC on 2021-08-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.03 | 69,781 | $770K | 24.4% |
| 2 | $11.03 | 69,781 | $770K | 24.4% |
| 3 | $11.17 | 72,219 | $807K | 25.6% |
| 4 | $11.17 | 72,219 | $807K | 25.6% |
| Total | $11.10 avg | 284,000 | $3.2M | 100% |
| Filing → |
| EOLS | BUY | 2023-02-06 | $565K | — | Filing → |
| EOLS | SELL | 2023-02-06 | $818K | — | Filing → |
| EOLS | SELL | 2022-10-07 | $689K | — | Filing → |